The U.S. government recently proposed rescheduling cannabis from a Schedule I to a Schedule III drug (https://www.dea.gov/drug-information/drug-scheduling) — basically signaling it has some accepted medical use and a moderate to low potential for physical and psychological dependence. But what does this mean in the real world exactly? Sanjay talks with “The Pot Doc” Dr. Staci Gruber (https://www.drstacigruber.com/) , Director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program in Boston, to explore the possible impacts of this rescheduling on research, healthcare, and yes – even you.
Learn more about your ad choices. Visit podcastchoices.com/adchoices (https://podcastchoices.com/adchoices)
